Carsten Riether

Bern, BE, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications

Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.

Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.

Journal: Haematologica
Published: March 20, 2026

CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic target.

CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic target.

Journal: Leukemia
Published: August 12, 2025

High-dimensional spatiotemporal single-cell atlas and 3D imaging of the bone marrow microenvironment during CML progression.

High-dimensional spatiotemporal single-cell atlas and 3D imaging of the bone marrow microenvironment during CML progression.

Journal: Blood
Published: May 09, 2025

High-Dimensional Spatiotemporal Single-Cell Atlas and 3D imaging of Bone Marrow Microenvironment during CML Progression.

High-Dimensional Spatiotemporal Single-Cell Atlas and 3D imaging of Bone Marrow Microenvironment during CML Progression.

Journal: Blood
Published: May 09, 2025

The Role of the Bone Morphogenetic Protein Antagonist Noggin in Nucleus Pulposus Intervertebral Disc Cells.

The Role of the Bone Morphogenetic Protein Antagonist Noggin in Nucleus Pulposus Intervertebral Disc Cells.

Journal: International journal of molecular sciences
Published: September 03, 2024

IL-33/ST2 signaling in ILC2s drives exhaustion and myeloid skewing of HSCs in response to hematopoietic stress and aging.

IL-33/ST2 signaling in ILC2s drives exhaustion and myeloid skewing of HSCs in response to hematopoietic stress and aging.

Journal: iScience
Published: July 08, 2024

Intestinal low-abundant bacteria drive MyD88/Trif-dependent CD8+ T cell exhaustion in chronic myeloid leukemia.

Intestinal low-abundant bacteria drive MyD88/Trif-dependent CD8+ T cell exhaustion in chronic myeloid leukemia.

Journal: Cell reports
Published: May 21, 2024

IL-9 secreted by leukemia stem cells induces Th1-skewed CD4+ T cells, which promote their expansion.

IL-9 secreted by leukemia stem cells induces Th1-skewed CD4+ T cells, which promote their expansion.

Journal: Blood
Published: February 12, 2024

IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.

IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.

Journal: Cell reports. Medicine
Published: September 11, 2023

Author Correction: Tumour mutations in long noncoding RNAs enhance cell fitness.

Author Correction: Tumour mutations in long noncoding RNAs enhance cell fitness.

Journal: Nature communications
Published: September 06, 2023

IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways.

IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways.

Journal: Science signaling
Published: August 29, 2023

The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell-Mediated Killing of AML Leukemic Stem Cells.

The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell-Mediated Killing of AML Leukemic Stem Cells.

Journal: Cancer immunology research
Published: August 24, 2023
Showing 1-12 of 67

Last Updated: 09/26/2026